These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20360715)

  • 1. Public database for HIV drug resistance in southern Africa.
    de Oliveira T; Shafer RW; Seebregts C
    Nature; 2010 Apr; 464(7289):673. PubMed ID: 20360715
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study.
    Lippman SA; Mooney AC; Puren A; Hunt G; Grignon JS; Prach LM; Gilmore HJ; Truong HM; Barnhart S; Liegler T
    BMC Infect Dis; 2020 Mar; 20(1):248. PubMed ID: 32216752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical data marshalled to treat HIV.
    Clarke T
    Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV/AIDS. Tangled patent dispute over 'free' drug-resistance database.
    Cohen J
    Science; 2009 Feb; 323(5918):1156-7. PubMed ID: 19251598
    [No Abstract]   [Full Text] [Related]  

  • 5. Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa?
    Stevens WS; Wallis CL; Sanne I; Venter F
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):655-6. PubMed ID: 19935208
    [No Abstract]   [Full Text] [Related]  

  • 6. Licensing agreement supports the PASER study.
    AIDS Patient Care STDS; 2007 Oct; 21(10):776-7. PubMed ID: 17949276
    [No Abstract]   [Full Text] [Related]  

  • 7. Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.
    Martinson NA; Morris L; Gray G; Moodley D; Pillay V; Cohen S; Dhlamini P; Puren A; Bhayroo S; Steyn J; McIntyre JA
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):148-53. PubMed ID: 17117145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.
    Casadellà M; Noguera-Julian M; Sunpath H; Gordon M; Rodriguez C; Parera M; Kuritzkes DR; Marconi VC; Paredes R
    AIDS; 2016 Apr; 30(7):1137-40. PubMed ID: 26807968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance mutations in HIV: new bioinformatics approaches and challenges.
    Blassel L; Zhukova A; Villabona-Arenas CJ; Atkins KE; Hué S; Gascuel O
    Curr Opin Virol; 2021 Dec; 51():56-64. PubMed ID: 34597873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.
    Zhukova A; Cutino-Moguel T; Gascuel O; Pillay D
    J Infect Dis; 2017 Dec; 216(suppl_9):S820-S823. PubMed ID: 29029155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV drug resistance in Africa: an emerging problem that deserves urgent attention.
    Moreno M; Caballero E; Mateus RM; Samba F; Gil E; Falcó V
    AIDS; 2017 Jul; 31(11):1637-1639. PubMed ID: 28481772
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV in Europe--a growing threat.
    Wahren B
    J Clin Virol; 2001 May; 21(2):171-3. PubMed ID: 11417524
    [No Abstract]   [Full Text] [Related]  

  • 13. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 14. Report from the XV International HIV Drug Resistance Workshop.
    Kuritzkes DR
    AIDS Clin Care; 2006 Sep; 18(9):83-4. PubMed ID: 16995272
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa.
    Manasa J; Danaviah S; Lessells R; Elshareef M; Tanser F; Wilkinson E; Pillay S; Mthiyane H; Mwambi H; Pillay D; de Oliveira T
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):763-9. PubMed ID: 27002368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients].
    Cabrera C; Clotet B
    Med Clin (Barc); 2005 Apr; 124(16):618-9. PubMed ID: 15871779
    [No Abstract]   [Full Text] [Related]  

  • 17. In Defense of Baseline Genotypic Antiretroviral Resistance Testing.
    Lang R; Krentz HB; Gill MJ
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):e1-e2. PubMed ID: 31809365
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant strains of HIV increase sharply in Japan. Health officials step up efforts to improve diagnosis and ensure adherence to treatment.
    McCurry J
    Lancet; 2003 Sep; 362(9389):1052. PubMed ID: 14526781
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.